Last reviewed · How we verify
NCT06724874
Online Web-Based Deep Relaxation Exercise Applied to Pregnant Women on Maternal Fetal Attachment and Pregnancy Perception
NA trial testing Web-Based Deep Relaxation Exercise in Maternal Fetal Attachment Pregnancy Perception in 80 participants. Not yet recruiting.
15 April 2025
Quick facts
| Lead sponsor | Çankırı Karatekin University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 80 |
| Start date | 15 December 2024 |
| Primary completion | 15 April 2025 |
| Estimated completion | 15 June 2025 |
Drugs / interventions tested
- Web-Based Deep Relaxation Exercise
Conditions studied
- Maternal Fetal Attachment Pregnancy Perception — all drugs for Maternal Fetal Attachment Pregnancy Perception →
- Pregnancy Perception — all drugs for Pregnancy Perception →
Sponsor
Çankırı Karatekin University
Who can join
Adults 18 to 45, female only, with Maternal Fetal Attachment Pregnancy Perception or Pregnancy Perception. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was planned as a pre-test post-test randomized controlled study in order to determine the effects of an online web-based deep relaxation exercise applied to pregnant women on maternal-fetal attachment and pregnancy perception. The study is planned to be conducted with pregnant women reached through social media (such as Facebook, Messenger, Instagram). The study is planned to be conducted between December 15, 2024 and June 15, 2025. The universe of the study will consist of pregnant women who volunteer to participate in online deep relaxation exercises and share their contact information. When the power analysis was performed, the sample size was calculated as a total of 80 pregnant women (40 experimental, 40 control), assuming that the web-based deep relaxation exercise applied would increase the mean maternal-fetal attachment score (72.25±7.16) (Güney and Uçar, 2019) by four and a half points at a 5% error level, a two-sided significance level, a 95% confidence interval, and an 80% ability to represent the universe (https://www.stat.ubc.ca/\~rollin/stats/ssize/n2.html). Pregnant women to be included in the groups will be selected from the relevant population using the improbable random sampling method.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06724874
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Çankırı Karatekin University trials
Trials by the same sponsor.
- NCT07326267 — School-Based Sensory Processing and Daily Living Skills-Focused Occupational Therapy Program · NA · not yet recruiting
- NCT07512544 — Building Sustainability Competencies in Future Nurses · NA · not yet recruiting
- NCT07266870 — Effect of CORE on Knowledge and Attitude Levels Regarding Pain Assessment · NA · completed
- NCT07306468 — Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life · recruiting
- NCT07207655 — Knowledge and Beliefs of Hearing Impaired Individuals Regarding Human Papillomavirus (HPV) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06724874 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Çankırı Karatekin University
- Last refreshed: 9 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06724874.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing